- Directors and Auditors
- Articles of Association
- General Meetings
- - Previous General Meetings
- Insider Trading
Dignitana Publishes December Newsletter
Dignitana Release - wkr0006.pdf
Dignitana AB today publishes the December 2019 edition of the company newsletter, attached to this release.
The Dignitana IN BRIEF newsletter is published monthly for Dignitana shareholders. Newsletters are posted to the Dignitana website and are available by email subscription here.
For More Information Contact
Investor Relations +1 469 518 5031 firstname.lastname@example.org
Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001. Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Erik Penser Bank AB, Certified Adviser, +46 (0) 8 463 83 00 email@example.com www.penser.se Learn more at www.dignitana.se and www.dignicap.com.
Dignitana enters Hong Kong market with leading distributor Science International Corporation
Dignitana newsletter highlights growth, media coverage and exemplary customer satisfaction
Innovative treatment for hair loss from chemotherapy to be presented at Stora Aktiedagen
Dignitana hires Johan Johansson to Head Operations, Research and Development
Aktiespararna women’s event to feature Dignitana CEO Catarina Mård Löwenadler
Dignitana newsletter highlights growth and customer satisfaction